Home Compare EUZ.DE vs NOVO-B.CO
Stock Comparison · Single-driver result

Eckert & Ziegler vs Novo Nordisk A/S: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Novo Nordisk A/S carrying a narrow edge on growth. Eckert & Ziegler SE still has the edge on growth, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Growth points more clearly toward Eckert & Ziegler SE, even if the broader score still leans toward Novo Nordisk A/S.

Trajectory Similarity
0.69
Moderately similar
Peer-set rank: #6
within Eckert & Ziegler SE's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

Most of the shared profile comes through capital structure and margin consistency.

Similarity drivers
capital structuremargin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
EUZ.DE
Eckert & Ziegler SE
56
Peer-Score
Signal qualityHigh
vs
NOVO-B.CO
Novo Nordisk A/S
58
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: EUZ.DE vs NOVO-B.CO Profitability 78 89 Stability 11 23 Valuation 69 86 Growth 50 6 EUZ.DE NOVO-B.CO
Gap Ranking
#1 Growth +44
#2 Valuation +17
#3 Stability +12
#4 Profitability +11
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EUZ.DE and NOVO-B.CO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EUZ.DENOVO-B.CO Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against Eckert & Ziegler SE.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Eckert & Ziegler SE sits in the stronger part of the group on growth, while Novo Nordisk A/S is closer to mid-pack.
Valuation
Both rank well on valuation, but Novo Nordisk A/S still sits higher.
Growth — Dominant Gap
EUZ.DE
50
NOVO-B.CO
6
Gap+44in favour of EUZ.DE

The current lead is backed by a stronger multi-year growth trajectory.

What keeps the gap from being one-sided

Eckert & Ziegler SE still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

Growth is the clearest driver of the lead, with valuation adding further support — though growth still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the EUZ.DE vs NOVO-B.CO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how EUZ.DE and NOVO-B.CO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.